News

It’s prescribed to treat a condition experienced by roughly 25% of Americans, but there's a report of “burnt or melted ...
View the latest Zydus Lifesciences Ltd. (532321) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Zydus Wellness share price has remained volatile amid fluctuating market. In last one year, the stock has gained over 4.16 ...
Zydus Wellness shares rallied 7 per cent on Wednesday, after True North exited by divesting its entire 7.27 per cent stake ...
Zydus Lifesciences Ltd announced the closure of a USFDA follow-up inspection at its oncology injectable site near Matoda, ...
Agenus has signed $141m partnership agreements with Zydus Lifesciences and its subsidiaries to enhance clinical developments and advance manufacturing globally while expanding patient access to ...
Zydus Wellness Ltd. has seen 46.27 lakh shares change hands in the pre-open block deal window on Tuesday, June 17. The shares ...
Zydus Lifesciences announced that a recent FDA audit at its Ahmedabad oncology unit concluded with only two minor ...
Around 46.27 lakh shares of Zydus Wellness, equaling around 7.3 percent of the total equity in the firm, changed hands at Rs ...
The experimental ALS treatment usnoflast exhibited promising signs of slowed functional decline and improved breathing in a ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifesciences Ltd. (NSE: ZYDUSLIFE), including its ...
The acquisition will establish Zydus' presence in fast growing global biologics CDMO space. Acquired capabilities include cutting-edge biologics development and manufacturing services to serve the ...